Zuping Xia

1.3k citations

30 papers · 1.1k indexed · h-index 14

Impact in

Pathology and Forensic Medicine top 5%
- Cancer Mechanisms and Therapy
Organic Chemistry top 10%
- Synthesis and biological activity

Papers in

Pharmacology 4
- Pharmacogenetics and Drug Metabolism 4
Organic Chemistry 10
- Synthesis and biological activity 5

Co-authors: Charles D. Smith Yan Zhuang Andrew S. Kraft Zanna Beharry Kevin J. French Wenxue Wang Jian Ma Staci N. Keller
Journals: Molecular Cancer Therapeutics (3 papers)Journal of Medicinal Chemistry (3 papers)The Journal of Organic Chemistry (2 papers)Pharmacology Research & Perspectives (2 papers)Archiv der Pharmazie (2 papers)
Partner nations: United States Canada India

In The Last Decade

Zuping Xia

30 papers receiving 1.1k citations

Peers

Countries citing papers authored by Zuping Xia

Since Specialization

Citations

This map shows the geographic impact of Zuping Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuping Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuping Xia more than expected).

Fields of papers citing papers by Zuping Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuping Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuping Xia. The network helps show where Zuping Xia may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zuping Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zuping Xia Line = papers co-authored together Zuping Xia links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characterization of Cytosolic Glutathione S-Transferases Involved in the Metabolism of the Aromatase Inhibitor, Exemestane Drug Metabolism and Disposition ·Ludwig Zeschko, Christy J.W. Watson, Zuping Xia, Amador Grinyó Guzmàn, Philip Lazarus	2021	4
2	Identification and Quantification of Novel Major Metabolites of the Steroidal Aromatase Inhibitor, Exemestane Drug Metabolism and Disposition ·Souvanic Roy, Amador Grinyó Guzmàn, Cristina I. Truica, EL Garcêz, Zuping Xia, Philip Lazarus	2018	10
3	Identification of the 4-Position of 3-Alkynyl and 3-Heteroaromatic Substituted Pyridine Methanamines as a Key Modification Site Eliciting Increased Potency and Enhanced Selectivity for Cytochrome P-450 2A6 Inhibition Journal of Medicinal Chemistry ·Travis T. Denton, Pramod K. Srivastava, Zuping Xia, Gang Chen, Christy J.W. Watson, Gwendoline Cheng Lian, Philip Lazarus	2018	9
4	Exemestane potency is unchanged by common nonsynonymous polymorphisms in CYP19A1: results of a novel anti‐aromatase activity assay examining exemestane and its derivatives Pharmacology Research & Perspectives ·Elena Kovač, Zuping Xia, Gang Chen, Philip Lazarus	2017	7
5	Impact of nonsynonymous single nucleotide polymorphisms on in-vitro metabolism of exemestane by hepatic cytosolic reductases Pharmacogenetics and Genomics ·Amity Platt, Zuping Xia, Ying Liu, Gang Chen, Philip Lazarus	2016	26
6	Pharmacokinetics of 3’-O-Retinoyl-5-fluoro-2’-deoxyuridine (RFUdR), a Dual Acting Mutually Masking Prodrug, and Its Metabolites in Tumor Bearing Mice Current Drug Delivery ·Zuping Xia, Edward E. Knaus, Leonard I. Wiebe	2013	2
7	Discovery and Evaluation of Inhibitors of Human Ceramidase Molecular Cancer Therapeutics ·K. Seevakan, Zuping Xia, Magda Junqueira, Yan Zhuang, Wenxue Wang, Charles D. Smith	2011	57
8	Improved synthesis of a fluorogenic ceramidase substrate Bioorganic & Medicinal Chemistry ·Zuping Xia, K. Seevakan, Charles D. Smith	2010	5
9	The Pim protein kinases regulate energy metabolism and cell growth Proceedings of the National Academy of Sciences ·Zanna Beharry, Sandeep Mahajan, Marina Zemskova, Ying-Wei Lin, Baby G. Tholanikunnel, Zuping Xia, Charles D. Smith, Andrew S. Kraft	2010	104
10	Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells Molecular Cancer Therapeutics ·Zanna Beharry, Marina Zemskova, Sandeep Mahajan, Fengxue Zhang, Jian Ma, Zuping Xia, Michelle M. Lilly, Charles D. Smith, Andrew S. Kraft	2009	83
11	Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases Journal of Medicinal Chemistry ·Zuping Xia, Christian Knaak, Jian Ma, Zanna Beharry, Campbell McInnes, Wenxue Wang, Andrew S. Kraft, Charles D. Smith	2008	168
12	Suppression of Ulcerative Colitis in Mice by Orally Available Inhibitors of Sphingosine Kinase Digestive Diseases and Sciences ·Lynn W. Maines, Leo R. Fitzpatrick, Kevin J. French, Yan Zhuang, Zuping Xia, Staci N. Keller, John J. Upson, Charles D. Smith	2007	153
13	Cellular palmitoylation and trafficking of lipidated peptides Journal of Lipid Research ·K. Seevakan, Zuping Xia, Charles D. Smith	2007	35
14	In vitro and cellular assays for palmitoyl acyltransferases using fluorescent lipidated peptides Methods ·Charles Ducker, K. Seevakan, Zuping Xia, Charles D. Smith	2006	8
15	Discovery and characterization of inhibitors of human palmitoyl acyltransferases Molecular Cancer Therapeutics ·Charles Ducker, S. Sultoni, Magda Junqueira, Staci N. Keller, Yan Zhuang, Zuping Xia, 和広深谷, Charles D. Smith	2006	80
16	Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-Based Inhibitors of Human N-Myristoyltransferase-1 Journal of Pharmacology and Experimental Therapeutics ·Kevin J. French, Yan Zhuang, Randy S. Schrecengost, Jean E. Copper, Zuping Xia, Charles D. Smith	2004	31
17	Solution structure, enzymatic, and non-enzymatic reactivity of 3-isoadenosylcobalamin, a structural isomer of coenzyme B12 with surprising coenzymic activity Journal of Inorganic Biochemistry ·Kenneth L. Brown, Xiang Zou, Guodong Chen, Zuping Xia, Helder M. Marques	2003	5
18	ChemInform Abstract: Total Synthesis of Dendroamide A (I), a Novel Cyclic Peptide That Reverses Multiple Drug Resistance. ChemInform ·Zuping Xia, Charles D. Smith	2001	5
19	Synthesis and Biological Evaluation of Butanoate, Retinoate, and Bis(2,2,2-trichloroethyl)phosphate Derivatives of 5-Fluoro-2′-deoxyuridine and 2′,5-Difluoro-2′-deoxyuridine as Potential Dual Action Anticancer Prodrugs Archiv der Pharmazie ·Zuping Xia, Leonard I. Wiebe, Gerald G. Miller, Edward E. Knaus	1999	13
20	Syntheses of [2-2H]-5-ethynyl-1-(β-D-ribofuranosyl)imidazole-4-carboxamide and 5-ethynyl-1-([5-3H]-β-D-ribofuranosyl)imidazole-4-carboxamide (EICAR) Journal of Labelled Compounds and Radiopharmaceuticals ·Noriaki Minakawa, Akira Matsuda, Zuping Xia, Leonard I. Wiebe, Edward E. Knaus	1996	2

About Zuping Xia

Zuping Xia is a scholar working on Pharmacology, Organic Chemistry, Molecular Biology, Cell Biology and Toxicology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Synthesis and biological activity (5 papers), Cancer Mechanisms and Therapy (5 papers), Estrogen and related hormone effects (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Retinoids in leukemia and cellular processes (4 papers), Glycosylation and Glycoproteins Research (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (303 citations), Organic Chemistry (320 citations), Molecular Biology (694 citations), Oncology (253 citations) and Cell Biology (127 citations). Zuping Xia has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Charles D. Smith, Charles D. Smith, Yan Zhuang, Andrew S. Kraft, Zanna Beharry, Kevin J. French, Wenxue Wang, Jian Ma, Staci N. Keller and Ying-Wei Lin. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Pharmacology Research & Perspectives and Archiv der Pharmazie.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact